SARAH CANNON CANCER CENTER
Sarah Cannon Cancer Center (TriStar Sarah Cannon) is a community-based oncology network of 8 HCA Healthcare-affiliated hospitals across Tennessee and Southern Kentucky, employing over 100 oncologists and treating more than 4,000 newly diagnosed cancer patients annually through diagnosis, treatment, transplant, and clinical trial services.
- Company typePrivate
- Founded1991
- HeadquartersNashville, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What SARAH CANNON CANCER CENTER does
Sarah Cannon Cancer Center, doing business as TriStar Sarah Cannon, is a community-based oncology network operating 8 affiliated medical facilities across Tennessee and Southern Kentucky under the TriStar Health division of HCA Healthcare. Founded in 1991 when Sarah Ophelia Colley Cannon (the entertainer known as "Cousin Minnie Pearl") lent her name following her own breast cancer treatment, the network has grown to become what it describes as the largest community-based, privately funded cancer diagnostic and treatment center in the United States. All 8 facilities are accredited by the American College of Surgeons Commission on Cancer, and the flagship campus at TriStar Centennial Medical Center is Joint Commission accredited. The network employs more than 100 medical oncologists, gynecologic oncologists, hematologists, radiation oncologists, pathologists, and surgeons, and diagnoses and treats over 4,000 newly diagnosed cancer patients annually.
The service portfolio spans the full oncology continuum: breast services anchored by the first Tomosynthesis (3D mammography) system in Middle Tennessee; a Center for Blood Cancers performing autologous and allogeneic hematopoietic progenitor cell transplantation (144+ and 37+ transplants respectively); diagnostic imaging and image-guided procedures including PET, MRI, CT, stereotactic breast biopsy, EBUS, and SuperDimension electromagnetic navigation bronchoscopy; interventional radiology offerings such as chemoembolization, Y90 radioembolization, and radiofrequency ablation; radiation oncology; and robotic-assisted surgery using the da Vinci Surgical System. Support services include lymphedema management, patient navigation, support groups, and the affiliated 501(c)(3) PearlPoint Cancer Support (formerly The Minnie Pearl Cancer Foundation), which provides free counseling, nutrition guidance, and clinical-trial information.
Revenue is generated primarily through professional medical services billed across insurance plans, with supplementary income from clinical-trial activity conducted through the affiliated Sarah Cannon Research Institute — the largest community-based clinical trials program in the U.S., enrolling approximately 1,400 patients annually across 10 therapeutic areas. Patients access the network via physician referrals, emergency department pathways, and the TriStar MedLine phone service (800-242-5662). Geographic reach spans Tennessee (Nashville, Smyrna, Hermitage, Chattanooga), Southern Kentucky (Bowling Green), and Northern Alabama. Operational control sits with HCA Healthcare, the parent conglomerate, through the TriStar Health division.
SARAH CANNON CANCER CENTER firmographics
Firmographics- Name
- SARAH CANNON CANCER CENTER
- Legal name
- TriStar Sarah Cannon Cancer Center
- Website
- https://tristarsarahcannon.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sarah Cannon Cancer Center (TriStar Sarah Cannon) is a community-based oncology network of 8 HCA Healthcare-affiliated hospitals across Tennessee and Southern Kentucky, employing over 100 oncologists and treating more than 4,000 newly diagnosed cancer patients annually through diagnosis, treatment, transplant, and clinical trial services.
- Ownership category
- akta.pro rank
SARAH CANNON CANCER CENTER industry classification
Industry- Product category
- Oncology / Cancer Care Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (62211)
- SIC
- Services-Health Services (8000), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Breast Oncology (HLAKAFAJ), Surgical Oncology (HLAKAFAG)
Keywords
Where SARAH CANNON CANCER CENTER is headquartered
LocationHeadquarters
- HQ city
- Nashville
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
SARAH CANNON CANCER CENTER business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Medical Services Revenue: Revenue generated from providing cancer diagnosis, treatment, and supportive care services. Services include diagnostic imaging, radiation therapy, chemotherapy, surgical procedures, and supportive care. Billed through insurance plans and includes patient pricing transparency.
- Clinical Trial Services: Sarah Cannon Research Institute conducts clinical trials in partnership with the network, providing access to investigational therapies and generating revenue through research support services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Standard medical services pricing |
Go-to-market motion1 record
Distribution channels9 records
Marketing channels8 records
SARAH CANNON CANCER CENTER product offering
Product offeringCore offering
TriStar Sarah Cannon Cancer Center is a network of 8 affiliated medical facilities in Tennessee and Southern Kentucky that delivers comprehensive cancer diagnosis, treatment, and supportive care services. Core services include breast imaging and care, blood cancer transplantation, diagnostic imaging and biopsies, interventional radiology, radiation oncology, robotic-assisted surgery, lymphedema management, and clinical trial access through the Sarah Cannon Research Institute.
Product overview
Sarah Cannon Cancer Center is a network of 8 affiliated medical facilities in Tennessee and Southern Kentucky providing comprehensive cancer diagnosis and treatment. The center operates as a unified network offering a full continuum of care including Breast Services, Center for Blood Cancers with transplantation services, Diagnostic Imaging & Procedures (spanning X-Rays, CT, MRI, PET, mammography, Tomosynthesis, EBUS, EUS, and stereotactic/ultrasound-guided biopsies), Interventional Radiology (embolization and radiofrequency ablation), Lymphedema Management, Radiation Oncology, and Robotic-Assisted Surgery using the da Vinci system. Support services include Support Groups & Services, Clinical Trials through Sarah Cannon Research Institute, and PearlPoint Cancer Support. The network has grown to become the largest community-based, privately funded cancer diagnostic and treatment center in the country.
Differentiator
Problem solved
Functional benefit
Brands
- Sarah Cannon Cancer Center for Blood Cancers: Comprehensive services for patients requiring autologous and allogeneic hematopoietic progenitor cell transplantation, including the collection and processing of cellular therapy products.
Products and services
- Breast Services Comprehensive breast cancer screening, diagnosis, and treatment for women including digital mammography, Tomosynthesis (3D mammography), breast MRI, and minimally invasive image-guided breast biopsies. The center offers the first and only Tomosynthesis technology in Middle Tennessee.
- Center for Blood Cancers Comprehensive services for adult patients requiring autologous and allogeneic hematopoietic progenitor cell transplantation, including collection and processing of cellular therapy products and care for patients undergoing high-dose chemotherapy. Program has performed 144+ autologous transplants and 37+ allogeneic transplants under the direction of Program Director Ian W. Flinn MD, PhD.
- Diagnostic Imaging & Procedures Advanced diagnostic imaging services for cancer patients including X-Rays, CT Scan, Bone Scan, Mammogram, Breast MRI, PET, Colonoscopy, Endobronchial Ultrasound (EBUS), Endoscopic Ultrasound (EUS), Intraoperative Ultrasound, MRI, Stereotactic Breast Biopsy, Super Dimension Bronchoscopy, and Tomosynthesis.
- Interventional Radiology Minimally invasive targeted treatments for liver, lung, kidney, and soft tissue tumors including Liver Embolization, Chemoembolization, Radioembolization (Y90), and Radiofrequency Ablation (RFA). Chemoembolization and radioembolization are 80% active in hepatocellular tumors and 60% effective in liver metastases; RFA is 80% effective for cure of single tumors up to 4.5 cm (up to 4 tumors in one sitting).
- Lymphedema Management Treatment and management of lymphedema through exercises, wrapping, massage, pneumatic compression, and compression garments to reduce swelling and control pain for cancer patients.
- Radiation Oncology Cancer treatment using high-energy X-rays or particles to kill cancer cells, including external beam radiation therapy as primary treatment, neoadjuvant therapy, adjuvant therapy, and combination treatments with chemotherapy.
- Robotic-Assisted Surgery (da Vinci) Minimally invasive surgery using the da Vinci Surgical System for the treatment of bladder cancer, colorectal cancer, endometriosis, gynecologic cancer, kidney cancer, lung cancer, and prostate cancer through tiny 1-2 cm incisions with greater vision, precision, and control.
- Support Groups & Services Comprehensive support services including nutrition services, patient navigation, social services, and cancer registry. Support groups cover various cancer types including breast, brain, colorectal, melanoma, leukemia, lung, prostate, and others.
- Stereotactic Breast Biopsy Image-guided needle biopsy using mammography to locate and sample suspicious breast tissue using core needle or vacuum-assisted device techniques for precise diagnosis.
- EBUS (Endobronchial Ultrasound) Endobronchial ultrasound procedure for diagnosis of lung cancer, infections, and diseases causing enlarged lymph nodes, allowing transbronchial needle aspiration without conventional surgery.
- Clinical Trials Access to clinical trials through the Sarah Cannon Research Institute, offering investigational and approved therapies and enabling patients to participate in research studies close to home. Approximately 1,400 patients are enrolled in treatment protocols annually.
- PearlPoint Cancer Support Free cancer supportive services including the My PearlPoint online tool, cancer library, clinical trial information, nutrition consultations, and one-on-one guidance for cancer survivors and co-survivors, available regardless of location.
- CT Scan-Guided Biopsy CT-guided needle biopsy for diagnosis of lung cancer, kidney cancers, liver masses, pancreatic masses, retroperitoneal masses, bone, and fluid aspiration throughout the body.
Quantifiable outcome
- Over 4,000 newly diagnosed cancer patients treated annually
- +4 more outcomes
Companies that use SARAH CANNON CANCER CENTER
Customer profileNamed customers4 records
Segments6 records
Ideal customer profiles1 record
SARAH CANNON CANCER CENTER technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
SARAH CANNON CANCER CENTER partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Sarah Cannon Research Institute (SCRI)coreSarah Cannon Research Institute is an industry leader in clinical trials dedicated to advancing solutions for patient care through clinical research. It is the largest community-based program in the nation, conducting clinical trials in ten therapeutic areas. Through affiliation, TriStar Sarah Cannon patients gain access to approximately 1,400 patients annually participating in treatment protocols.
- Tennessee OncologycoreTennessee Oncology is one of the largest physician-owned oncology practices in the country with more than fifty board-certified medical oncologists, hematologists, radiation oncologists and gynecologic oncologists in over 26 clinics in the Middle Tennessee area. Provides transplant physician services and coverage 7 days per week / 24 hours per day.
- PearlPoint Cancer SupportcorePearlPoint Cancer Support (formerly The Minnie Pearl Cancer Foundation) is a public 501(c)(3) nonprofit organization committed to providing personalized guidance and compassionate support to any adult impacted by cancer. Services are FREE of charge regardless of location and include My PearlPoint online tool, online cancer library, clinical trial information, nutrition consultations, and supportive services.
- TriStar Centennial Medical CentercoreA 615-bed tertiary care medical facility, Joint Commission accredited, part of the HCA TriStar division and Sarah Cannon Cancer Network of Excellence. Houses integrated medical team in clinical, collections and cell processing facilities for blood cancer treatment.
- Gilda's Club NashvilleminorFree of charge to everyone, Gilda's Club Nashville is an affiliate of the Cancer Support Community providing a non-residential home-like gathering place where people living with cancer can join with others to build social and emotional support.
- American Cancer SocietyminorNational nonprofit organization providing cancer support groups, education, and resources. Multiple support groups listed including I Can Cope, Look Good Feel Better, and general cancer support groups in multiple counties.
- Leukemia & Lymphoma SocietyminorNational nonprofit organization providing support groups for leukemia, lymphoma, and blood-related cancers. Family Support Group meets at Gilda's Club Nashville on the 1st Monday of each month.
Scale indicators6 records
Recent moves7 records
Expansion highlights4 records
SARAH CANNON CANCER CENTER competitors and assessment
Company assessmentDirect peers
- Tennessee Oncology: One of the largest physician-owned oncology practices in the U.S., with 50+ board-certified specialists across 26+ clinics in Middle Tennessee. Direct peer — already a strategic partner of Sarah Cannon for transplant coverage, and a primary competitor for community oncology referrals.
- City of Hope: NCI-designated comprehensive cancer center with a network of community practice sites across California, Arizona, Illinois, and Georgia. Direct peer given its hybrid academic-community oncology model — a template Sarah Cannon could follow under HCA's umbrella.
- Cancer Treatment Centers of America (CTCA): Network of specialty oncology hospitals and outpatient centers focused exclusively on cancer diagnosis, treatment, and supportive care. Direct peer — comparable community-based specialty positioning and integrated supportive services model.
- Memorial Sloan Kettering Cancer Center: NCI-designated comprehensive cancer center delivering diagnosis, treatment, and clinical research across solid tumors and hematologic malignancies. Direct peer offering overlapping medical, radiation, and surgical oncology services plus an integrated research program akin to SCRI.
- Moffitt Cancer Center: NCI-designated comprehensive cancer center in Tampa, FL operating a hospital-based and outpatient oncology model. Direct peer in specialty cancer hospital delivery and clinical research infrastructure.
- MD Anderson Cancer Center: NCI-designated comprehensive cancer center providing the full continuum of oncology diagnosis, treatment, and research across all major cancer types. Direct peer — same specialty oncology positioning as Sarah Cannon, though at a much larger academic scale.
Broad incumbents
- Duke Cancer Institute: NCI-designated comprehensive cancer center within the Duke University Health System, offering multidisciplinary oncology care and clinical trials. Broad incumbent peer at the academic end of the cancer care spectrum.
- Mayo Clinic Comprehensive Cancer Center: NCI-designated comprehensive cancer center embedded in a large multi-specialty health system. Broad incumbent offering overlapping oncology services at much greater scale and academic prestige than Sarah Cannon.
Others
- Sarah Cannon Research Institute (SCRI): Affiliated clinical research organization running the largest community-based oncology trial program in the U.S. Sister entity under the Sarah Cannon umbrella — comparable for clinical trial operations benchmarking, though operating as a research services platform rather than a treating provider.
Regional players
- Vanderbilt-Ingram Cancer Center: NCI-designated comprehensive cancer center based in Nashville, TN — same metro market as Sarah Cannon's flagship. Regional peer offering competing medical, radiation, and surgical oncology plus clinical trials in the same patient catchment.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
SARAH CANNON CANCER CENTER social profiles
Digital presenceSARAH CANNON CANCER CENTER financial estimates
Financial estimateRevenue estimate
Valuation estimate
SARAH CANNON CANCER CENTER leadership team
Management profileNumber of profiles
Profiles1 record
SARAH CANNON CANCER CENTER subsidiaries and ownership
Company hierarchySubsidiaries8 records
SARAH CANNON CANCER CENTER funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SARAH CANNON CANCER CENTER M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SARAH CANNON CANCER CENTER
What does SARAH CANNON CANCER CENTER do?
TriStar Sarah Cannon Cancer Center is a network of 8 affiliated medical facilities in Tennessee and Southern Kentucky that delivers comprehensive cancer diagnosis, treatment, and supportive care services. Core services include breast imaging and care, blood cancer transplantation, diagnostic imaging and biopsies, interventional radiology, radiation oncology, robotic-assisted surgery, lymphedema management, and clinical trial access through the Sarah Cannon Research Institute.
Is SARAH CANNON CANCER CENTER a public or private company?
SARAH CANNON CANCER CENTER is a private company. It is classified as corporate owned and is currently operating.
When was SARAH CANNON CANCER CENTER founded?
SARAH CANNON CANCER CENTER was founded in 1991. It employs 11 to 50 people.
Where is SARAH CANNON CANCER CENTER based?
SARAH CANNON CANCER CENTER is headquartered in Nashville, United States, in the North America region.
How does SARAH CANNON CANCER CENTER make money?
Two revenue lines are on record. Medical Services Revenue is the primary driver. The others are clinical Trial Services.
Who are SARAH CANNON CANCER CENTER's main competitors?
Direct peers on record are Tennessee Oncology, City of Hope, Cancer Treatment Centers of America (CTCA), Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center and MD Anderson Cancer Center. Broad incumbents are Duke Cancer Institute and Mayo Clinic Comprehensive Cancer Center. Sarah Cannon Research Institute (SCRI) is listed as an others. Vanderbilt-Ingram Cancer Center is listed as a regional player.
Does SARAH CANNON CANCER CENTER have an API?
No public API is recorded for SARAH CANNON CANCER CENTER.
What industry is SARAH CANNON CANCER CENTER in?
SARAH CANNON CANCER CENTER's product category is Oncology / Cancer Care Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 6223 and its SIC code is 8000.